ACP
CLX icon

Argyle Capital Partners’s Clorox CLX Stock Holding History

Argyle Capital Partners’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
+2,511
New +$241K 0.15% 159

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Argyle Capital Partners's CLX Position: Q2 2026 in Review

Argyle Capital Partners opened a new position in Clorox (CLX) in Q2 2026: 2,511 shares worth $240K. The stake represents 0.15% of the portfolio and ranks #159 among its holdings.

1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Argyle Capital Partners held 2,511 shares of Clorox worth $240K as of Q2 2026.
  • Clorox was a new Argyle Capital Partners position in Q2 2026.
  • Clorox made up 0.15% of Argyle Capital Partners's portfolio in Q2 2026, its #159 holding.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Argyle Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.